Non-binding offers for Galapagos’s cell therapies assets came mostly from financial investors, and none offered sufficient terms or financing to support the business, the company said. Galapagos’s exit from cell therapy work will lead to site closures in Europe, China, and the U.S.
The post Galapagos to Wind Down Cell Therapy Business After Search for a Buyer Comes Up Empty appeared first on MedCity News.
